RAC 1.61% $1.83 race oncology ltd

Ann: Bisantrene cGMP API Manufacturing Completed at Laurus Labs, page-52

  1. 983 Posts.
    lightbulb Created with Sketch. 2527
    As biotech investors in RAC, this is a very important point … “the recent drama at Race has not prevented or delayed the Race team from moving bisantrene forward at a cracking pace”. Thanks for the update Dr T!!

    These words are backed up by the two significant ASX PS announcements over the past week. Unfortunately (or fortunately if you are still accumulating) the market hasn’t really fully appreciated these updates. I would suggest this is because of the recent “drama at Race” which hasn’t been fully resolved are still causing investors to stay on the sidelines or sell the news.

    i feel there is more (even much better) bisantrene news coming shortly, as Dr T mentioned that team has moved “Bisantrene forward at a cracking pace”, however the official ASX announcements has yet to catch up to this pace .

    Together with confirmation of the go forward team and strategy, this should bring marginal investors from off the sidelines and move the sp meaningfully higher.

 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
(20min delay)
Last
$1.83
Change
-0.030(1.61%)
Mkt cap ! $311.7M
Open High Low Value Volume
$1.86 $1.91 $1.79 $169.3K 92.02K

Buyers (Bids)

No. Vol. Price($)
1 92 $1.83
 

Sellers (Offers)

Price($) Vol. No.
$1.87 3472 1
View Market Depth
Last trade - 16.10pm 19/07/2024 (20 minute delay) ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.